The market for contrast media is experiencing rapid growth at a rate of 7.4% and is expected to double within the next 8 years, reaching $12 billion. Voyageur is poised to benefit from this long-term bull market. This growth is crucial for their drug development initiatives, particularly as the potential value of new drugs successfully transitioning past phase one trials is expected to be substantially higher than other drugs, as value is based on market size. Additionally, the projected doubling of the barium market further underscores the significance of this growth trend, with a 7.4% growth rate representing a considerably high rate of expansion.
In the context of pharmaceutical consumables, a 7.4% growth rate is generally considered significant and relatively high. Pharmaceutical markets often have more modest growth rates compared to other industries, making a 7.4% growth rate notably high. This rate of growth indicates increasing demand, market expansion, and potentially lucrative opportunities for Voyageur.
The critical minerals required for contrast media will never keep up to demand at this rate. Why anyone would sell this stock is mind blowing.
https://www.gminsights.com/industry-analysis/contrast-media-market